IceCure Medical Ltd
ICCM | NASDAQ
$1.98
+$0.03 (+1.54%)
Sep 22, 2026, 12:58 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 3.38M | 3.29M | 3.23M | 3.09M | 4.14M | 3.87M |
Cost of Revenue | 2.15M | 1.84M | 1.93M | 1.64M | 1.94M | 1.42M |
Gross Profit | 1.23M | 1.45M | 1.3M | 1.45M | 2.2M | 2.44M |
Operating Income | -15.09M | -15.7M | -15.58M | -16.74M | -9.72M | -4.14M |
Interest Income | 37K | 378K | 924K | n/a | n/a | 412K |
Pretax Income | -15.06M | -15.32M | -14.65M | -16.98M | -9.9M | -3.73M |
Net Income | -15.06M | -15.32M | -14.65M | -16.98M | -9.9M | -3.73M |
Selling & General & Admin | 8.89M | 10.05M | 8.6M | 9.06M | 6.04M | 2.78M |
Research & Development | 7.43M | 7.1M | 8.27M | 9.12M | 5.88M | 3.81M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 16.32M | 17.15M | 16.88M | 18.18M | 11.92M | 6.59M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 38.67K |
Selling & Marketing Expenses | 1.04M | 1.14M | 4.44M | 1.04M | 1.92M | 330K |
Cost & Expenses | 18.47M | 18.99M | 18.81M | 19.82M | 13.86M | 8.01M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 2.12M | 1.7M | 1.52M | 1.24M | 969.85K | 570.96K |
Shares Outstanding (Diluted) | 2.12M | 1.7M | 1.52M | 1.24M | 969.85K | 570.96K |
EPS (Basic) | -7.10 | -9 | -9.60 | -13.69 | -10.20 | -8.40 |
EPS (Diluted) | -7.10 | -9 | -9.60 | -13.69 | -10.20 | -8.40 |
EBITDA | -14.8M | -15.36M | -15.25M | -16.5M | -9.55M | -4.08M |
EBIT | -15.09M | -15.7M | -15.58M | -16.5M | -9.55M | -4.14M |
Depreciation & Amortization | 295K | 332K | 323K | n/a | n/a | 63K |
Add to Watchlist
Select watchlists to add or remove ICCM